The treatment of diabetes mellitus type 2 is facilitated by using Geminor M2 Tablet 15s, a commonly recommended drug. Gemigliptin and metformin are the two active components combined inside this product. This product description offers detailed information about Geminor M2 Tablet 15’s, such as its mode of action, indications, dosage, possible adverse effects, and precautions.
Mechanism of Action:
Geminor M2 Tablet 15 contains the active ingredient Gemigliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Gemigliptin protects incretin hormones from breakdown by inhibiting the enzyme dipeptidyl peptidase-4. This includes the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). As a result of this inhibition, pancreatic beta cells secrete more insulin and produce less glucagon. Therefore, Gemigliptin aids type 2 diabetics in preserving healthy blood sugar levels.
The second ingredient in Geminor M2 Tablet 15 is metformin, a drug of the biguanide family. When an enzyme essential for glucose generation in the liver (a process known as gluconeogenesis) is inhibited, the liver produces less glucose. As a result of metformin’s ability to improve insulin sensitivity, more glucose is taken up by peripheral tissues. Also, blood sugar levels are easier to manage because of decreased intestinal glucose absorption.
Treating individuals with type 2 diabetes mellitus with Geminor M2 Tablet 15s is the intended use of this product. When diet and exercise alone do not give appropriate glycemic control, it is suggested in an addition to maintain a diet and exercise to achieve adequate control. This medicine is not designed to treat a type of diabetes or diabetic ketoacidosis in patients.
Dosage and Administration:
A patient’s glycemic control, renal function, and other parameters should be considered while determining the appropriate dose of Geminor M2 Tablet 15s to administer. It is typically suggested to begin treatment at a low dose and gradually raise the dosage to obtain the proper control over blood glucose levels.
One tablet should be taken orally once daily, before or after a meal, as the recommended beginning dosage for Geminor M2 Tablet 15s. The pill should be chewed or mashed in any way but should instead be taken on its whole with a full glass of water. It is essential to take the medication exactly as the healthcare expert has instructed about the dose.
Precautions and Contraindications:
Before beginning treatment with Geminor M2 Tablet 15s, it is essential to carefully study the many risks and conditions that should not be treated with this medication. Patients previously diagnosed with an extreme sensitivity to Gemigliptin, metformin, or any of the other components of the formulation should not take this drug under any circumstances.
The kidneys primarily eliminate metformin. Thus, individuals with poor renal function should exercise care while using Geminor M2 Tablet 15s. Renal function testing should be performed routinely, and individuals with renal impairment may need dose changes.
It may be necessary to temporarily stop using Geminor M2 Tablet 15 in case of severe infections, surgery, or trauma. A medical expert should be consulted for advice on modifying the dosage or temporarily stopping treatment in such circumstances.
Side effects from using Geminor M2 Tablet 15s are possible, as they are with any drug. The most often reported adverse reactions are nausea, vomiting, diarrhea, stomach pain, and lack of appetite. Most people with these adverse effects find that they are moderate, short-lived, and go away on their own.
Metformin has been linked to an uncommon but potentially life-threatening side effect termed lactic acidosis. Weakness, fatigue, muscular soreness, trouble breathing, stomach discomfort, and irregular pulse indicate lactic acidosis, characterized by a build-up of lactic acid in the body. Get medical help right once if you have any of these symptoms.
Before beginning treatment with Geminor M2 Tablet 15’s, it is essential to tell the healthcare practitioner about any pre-existing medical problems, drugs currently being taken, or allergies you have. Because of this, any possible adverse medication interactions or contraindications will be avoided.
The combination drug Geminor M2 Tablet 15’s treats and controls type 2 diabetes mellitus. It’s an effective combination of the diabetes medications metformin (a biguanide) and Gemigliptin (a DPP-4 inhibitor). The ideal blood sugar management may be attained and maintained with the aid of Geminor M2 Tablet 15’s by addressing numerous pathways involved in glucose regulation. Carefully adhere to the dose and instructions supplied by your healthcare provider, and always check in with them if you have any questions or concerns. Geminor M2 Tablet 15’s may be a helpful aid in treating type 2 diabetes mellitus if used and monitored correctly.